Matches in Wikidata for { <http://www.wikidata.org/entity/Q94067359> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q94067359 description "artículu científicu" @default.
- Q94067359 description "wetenschappelijk artikel" @default.
- Q94067359 description "наукова стаття" @default.
- Q94067359 name "MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS" @default.
- Q94067359 name "MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS" @default.
- Q94067359 type Item @default.
- Q94067359 label "MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS" @default.
- Q94067359 label "MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS" @default.
- Q94067359 prefLabel "MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS" @default.
- Q94067359 prefLabel "MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS" @default.
- Q94067359 P1433 Q94067359-B2BFD14D-0820-4484-8C74-C563120D7436 @default.
- Q94067359 P1476 Q94067359-A12B21FC-BB81-4175-9F7B-4341C589A9BB @default.
- Q94067359 P2093 Q94067359-2664A92D-A966-4CA4-96C9-E4273EB5E0CA @default.
- Q94067359 P2093 Q94067359-367C9C2F-7094-4ADE-87A3-5B2D414CBEAE @default.
- Q94067359 P2093 Q94067359-4F16890B-8054-4EF4-8E3D-207F1633AF72 @default.
- Q94067359 P2093 Q94067359-C0B28EBE-9E45-47BC-91A4-EA7E870CD0EA @default.
- Q94067359 P2093 Q94067359-D22897F7-48F8-4EE9-8671-8B9274BF2E96 @default.
- Q94067359 P304 Q94067359-0A3787AC-DDD9-4C0C-B6F4-7985E76F08D4 @default.
- Q94067359 P31 Q94067359-1BAF085E-C0CF-496C-B4CE-2FAF65D439D3 @default.
- Q94067359 P356 Q94067359-6E17D11E-A833-4540-9BA5-75BF4EF2C8BE @default.
- Q94067359 P433 Q94067359-4CC59AE0-103E-4D73-9DAF-8E99D5BE5362 @default.
- Q94067359 P478 Q94067359-675845E4-7970-4170-B460-9AC1D5D13986 @default.
- Q94067359 P50 Q94067359-AE8BC0E4-E8A0-4963-8B20-9993D5B78398 @default.
- Q94067359 P577 Q94067359-42D65C13-4003-4606-AB3D-B15AE4BB8E4E @default.
- Q94067359 P921 Q94067359-19E17A93-A1CB-4912-85E3-F0C3E4852BC3 @default.
- Q94067359 P932 Q94067359-DF3F7252-8A07-438D-A685-4FC947B89A87 @default.
- Q94067359 P356 NOY059.429 @default.
- Q94067359 P1433 Q15724471 @default.
- Q94067359 P1476 "MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS" @default.
- Q94067359 P2093 "Diana S Osorio" @default.
- Q94067359 P2093 "Jonathan L Finlay" @default.
- Q94067359 P2093 "Mohammad H Abu Arja" @default.
- Q94067359 P2093 "Scott Coven" @default.
- Q94067359 P2093 "Sharon Gardner" @default.
- Q94067359 P304 "i124-i124" @default.
- Q94067359 P31 Q13442814 @default.
- Q94067359 P356 "10.1093/NEUONC/NOY059.429" @default.
- Q94067359 P433 "Suppl 2" @default.
- Q94067359 P478 "20" @default.
- Q94067359 P50 Q84067475 @default.
- Q94067359 P577 "2018-06-22T00:00:00Z" @default.
- Q94067359 P921 Q422232 @default.
- Q94067359 P932 "6012657" @default.